Research programme: infectious disease vaccines - Merck

Drug Profile

Research programme: infectious disease vaccines - Merck

Alternative Names: Clostridium difficile vaccines - Merck

Latest Information Update: 12 Oct 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Merck & Co
  • Class Bacterial vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants; Toll-like receptor 9 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Preclinical Bacterial infections; Viral infections

Most Recent Events

  • 15 Sep 2009 This research programme is ongoing
  • 01 Jan 2008 Coley Pharmaceutical Group has been acquired by Pfizer
  • 16 Apr 2007 Preclinical trials in Bacterial infections in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top